quinazolines has been researched along with Left Ventricular Hypertrophy in 7 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 2 (28.57) | 18.2507 |
| 2000's | 2 (28.57) | 29.6817 |
| 2010's | 1 (14.29) | 24.3611 |
| 2020's | 2 (28.57) | 2.80 |
| Authors | Studies |
|---|---|
| Hanada, K; Itoh, K; Kato, T; Kawamura, Y; Kitayama, K; Kudo, N; Miura, N; Nakata, M; Narita, M; Nozaka, M; Tatara, Y; Tomita, H; Toyama, Y; Tsushima, M; Yokono, Y | 1 |
| Bruszt, K; Deres, L; Eros, K; Gallyas, F; Halmosi, R; Horvath, O; Kalman, N; Kovacs, D; Ordog, K; Radnai, B; Toth, K; Toth, S | 1 |
| Bartha, E; Deres, L; Eros, K; Gallyas, F; Halmosi, R; Hideg, K; Kalai, T; Lantos, J; Palfi, A; Riba, A; Sumegi, B; Toth, K | 1 |
| Bartha, E; Halmosi, R; Hideg, K; Kálai, T; Kereskai, L; Lantos, J; Magyar, K; Plozer, E; Solti, I; Sumegi, B; Szabados, E; Toth, K | 1 |
| Kawamura, K; Kubota, J; Nishimura, H; Oka, T; Okabe, M; Ueyama, M | 1 |
| Gatzka, C; Langenfeld, M; Schmieder, RE; Schobel, HP | 1 |
| Higaki, J; Kamide, K; Moriguchi, K; Nagai, M; Ogihara, T; Ohishi, M; Okamura, A; Rakugi, H; Satoh, N; Tuck, ML | 1 |
1 trial(s) available for quinazolines and Left Ventricular Hypertrophy
| Article | Year |
|---|---|
Treatment and post-treatment effects of alpha- versus beta-receptor blockers on left ventricular structure and function in essential hypertension.
Topics: Adrenergic alpha-Antagonists; Adrenergic beta-Antagonists; Adult; Double-Blind Method; Female; Heart Ventricles; Hemodynamics; Humans; Hypertension; Hypertrophy, Left Ventricular; Male; Metoprolol; Middle Aged; Quinazolines; Ventricular Function, Left | 1996 |
6 other study(ies) available for quinazolines and Left Ventricular Hypertrophy
| Article | Year |
|---|---|
Blockade of PAR-1 Signaling Attenuates Cardiac Hypertrophy and Fibrosis in Renin-Overexpressing Hypertensive Mice.
Topics: Animals; Collagen Type III; Cytokines; Disease Models, Animal; Extracellular Signal-Regulated MAP Kinases; Fibroblasts; Fibrosis; HEK293 Cells; Humans; Hypertension; Hypertrophy, Left Ventricular; Inflammation Mediators; Macrophages; Male; Mice, Inbred C57BL; Mice, Transgenic; Myocardium; Pyrroles; Quinazolines; Receptor, PAR-1; Renin; Signal Transduction; Transforming Growth Factor beta1; Up-Regulation; Ventricular Function, Left; Ventricular Remodeling | 2020 |
Mitochondrial protective effects of PARP-inhibition in hypertension-induced myocardial remodeling and in stressed cardiomyocytes.
Topics: Animals; Cells, Cultured; Citrate (si)-Synthase; DNA, Mitochondrial; Electrocardiography; Glutathione; Hypertension; Hypertrophy, Left Ventricular; Male; Membrane Potential, Mitochondrial; Mitochondria, Heart; Mitochondrial Proteins; Myocytes, Cardiac; Natriuretic Peptide, Brain; Piperidines; Poly(ADP-ribose) Polymerase Inhibitors; Quinazolines; Rats, Inbred SHR; Rats, Wistar | 2021 |
PARP-inhibitor treatment prevents hypertension induced cardiac remodeling by favorable modulation of heat shock proteins, Akt-1/GSK-3β and several PKC isoforms.
Topics: Animals; Blood Pressure; Extracellular Signal-Regulated MAP Kinases; Forkhead Transcription Factors; Gene Expression Regulation; Glycogen Synthase Kinase 3; Glycogen Synthase Kinase 3 beta; Heart Failure; HSP90 Heat-Shock Proteins; Hypertension; Hypertrophy, Left Ventricular; Isoenzymes; Male; Natriuretic Peptide, Brain; Nerve Tissue Proteins; Phosphorylation; Piperidines; Poly(ADP-ribose) Polymerase Inhibitors; Poly(ADP-ribose) Polymerases; Protein Kinase C; Proto-Oncogene Proteins c-akt; Quinazolines; Rats; Rats, Inbred SHR; Rats, Inbred WKY; Signal Transduction | 2014 |
PARP inhibition delays transition of hypertensive cardiopathy to heart failure in spontaneously hypertensive rats.
Topics: Administration, Oral; Animals; Blood Pressure; Cardiovascular Agents; Disease Models, Animal; Disease Progression; Enzyme Inhibitors; Extracellular Signal-Regulated MAP Kinases; Fibrosis; Glycogen Synthase Kinase 3; Glycogen Synthase Kinase 3 beta; Heart Failure; Hypertension; Hypertrophy, Left Ventricular; Isoenzymes; JNK Mitogen-Activated Protein Kinases; Male; Myocardium; Natriuretic Peptide, Brain; Oxidative Stress; p38 Mitogen-Activated Protein Kinases; Phosphorylation; Piperidines; Poly (ADP-Ribose) Polymerase-1; Poly(ADP-ribose) Polymerase Inhibitors; Poly(ADP-ribose) Polymerases; Protein Kinase C; Proto-Oncogene Proteins c-akt; Quinazolines; Rats; Rats, Inbred SHR; Signal Transduction; Time Factors; Ventricular Function, Left; Ventricular Remodeling | 2009 |
Long-term alpha 1 blockade does not reverse cardiac hypertrophy in spontaneously hypertensive rats.
Topics: Adrenergic alpha-Antagonists; Animals; Hemodynamics; Hypertension; Hypertrophy, Left Ventricular; Male; Norepinephrine; Quinazolines; Rats; Rats, Inbred SHR; Renin | 1993 |
The renin-angiotensin and adrenergic nervous system in cardiac hypertrophy in fructose-fed rats.
Topics: Adrenergic alpha-Antagonists; Angiotensin II; Animals; Antihypertensive Agents; Blood Glucose; Blood Pressure; Catecholamines; Diet; Fructose; Glucose Tolerance Test; Heart Rate; Hydralazine; Hyperinsulinism; Hypertrophy, Left Ventricular; Imidazoles; Insulin; Male; Myocardium; Olmesartan Medoxomil; Organ Size; Quinazolines; Rats; Rats, Sprague-Dawley; Receptors, Adrenergic, alpha; Receptors, Adrenergic, beta; Renin-Angiotensin System; Sympathetic Nervous System; Tetrazoles | 2002 |